输尿管软镜治疗孤立肾结石的系统评价
Efficacy and Safety of Ureteroscopy for Stone Disease in a Solitary Kidney: Findings From a Systematic Review.
PubMed 文献 · Urology · 2018-04-24
总体并发症114例(16.4%),无死亡病例,Clavien III级并发症低于0.5%。该综述确认输尿管软镜对该特殊人群有效、安全且可靠。
要点
- 孤立肾结石行输尿管软镜总体并发症率为16.4%(114/693)。
- 无死亡病例报告,Clavien III级并发症低于0.5%。
- 输尿管软镜对孤立肾结石患者是有效、安全且可靠的技术。
核心结论
- 该系统评价确认输尿管软镜对孤立肾结石患者有效、安全且可靠。
主要发现
- 总体报告114例(16.4%)并发症。
- 所有研究中均无死亡病例报告。
- Clavien III级并发症记录于低于0.5%的患者。
关键数值与推荐
- 总体并发症114例(16.4%),对象为693例孤立肾结石患者。
- Clavien III级并发症低于0.5%,无死亡病例。
临床怎么用
- 对孤立肾结石患者,输尿管软镜可作为兼顾结石清除与安全性的治疗选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Management of stone disease in solitary kidney remains a difficult treatment entity for the urologist. The challenge exists to deliver high clearance while maintaining strong safety profile. Twelve eligible studies were included, comprising a total of 693 patients with a male:female ratio of 2:1. Overall, 114 (16.4%) complications were reported. No fatalities were reported in any of the studies. Clavien III complications were recorded in less than 0.5% of the patients. This review confirms the effectiveness, safety, and reliability of this technique for this unique cohort of patients.
来源:Urology,查看原文。版权归原作者所有。
引用
- Pietropaolo A, Jones P, Whitehurst L, et al. Efficacy and Safety of Ureteroscopy for Stone Disease in a Solitary Kidney: Findings From a Systematic Review. Urology. 2018. PMID: 29702154. doi:10.1016/j.urology.2018.03.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。